What Is Bioprinting?

Bioprinting is the additive manufacture of biological constructs by depositing living cells together with supporting biomaterials in a controlled, layer-by-layer pattern. It applies the motion control and toolpath planning of three-dimensional printing to a payload that must stay alive through the process, which imposes constraints no conventional printing process faces: mild temperatures, aqueous chemistry, low shear, sterility, and a build time short enough that cells at the bottom of the construct survive until the top is finished. The output is a structure whose geometry, cell placement, and mechanical properties are all specified in advance, usually from medical imaging data or a computer-aided design model.

The field emerged from the convergence of biomedical engineering, tissue engineering, and polymer science in the early 2000s, and it is distinguished from ordinary medical three-dimensional printing, which produces surgical guides, implants, and anatomical models from inert materials rather than from cells.

Printing Modalities

Three deposition approaches dominate, each with a different resolution and cell density tradeoff. Extrusion printing pushes a viscous cell-laden material through a nozzle under pneumatic, piston, or screw drive, and tolerates high cell densities and a wide range of materials at the cost of shear stress at the nozzle wall and feature sizes typically above 100 micrometers. Inkjet printing ejects picoliter droplets thermally or piezoelectrically, achieving finer resolution but requiring low-viscosity formulations that limit structural strength. Laser-assisted printing uses a pulsed beam to transfer material from a donor ribbon without a nozzle, avoiding shear damage and placing material at a resolution of tens of micrometers, fine enough to deposit single cells, though throughput and system complexity are worse. Vat photopolymerization methods add a fourth route, curing whole layers optically. A review that introduces bioprinting and its practical constraints compares these mechanisms alongside the cell viability each typically achieves.

Bioinks and Crosslinking

The bioink determines both what can be printed and what the printed construct becomes. Formulations combine cells with hydrogel-forming polymers such as alginate, gelatin methacryloyl, collagen, fibrin, hyaluronic acid, or decellularized extracellular matrix, sometimes reinforced with synthetic thermoplastics printed in parallel. Crosslinking may be ionic, as with calcium-triggered alginate gelation, thermal, or photochemical using visible-light initiators chosen to limit radical damage to cells. Formulation involves a direct conflict: raising polymer concentration improves shape fidelity and stiffness but slows nutrient diffusion and restricts the cell spreading and remodeling needed for tissue to mature. Work on biomaterial inks for extrusion-based printing sets out the rheological properties, shear thinning behavior, yield stress, and recovery time, that determine whether a formulation holds its shape after leaving the nozzle.

Vascularization and Tissue Maturation

The limit on construct thickness is oxygen and nutrient transport. Cells more than roughly 200 micrometers from a perfused channel become hypoxic, so any tissue larger than a thin sheet requires a built-in vascular network. Strategies include printing sacrificial materials that are later flushed out to leave open channels, coaxial nozzles that extrude hollow filaments directly, and embedded printing into a supporting bath that holds soft structures in place while they crosslink. Printed constructs are then usually transferred to a perfusion bioreactor, where controlled flow, mechanical loading, and electrical stimulation guide cells toward the phenotype and matrix organization of native tissue. A review of bioprinting in tissue engineering covering classic and hybrid approaches surveys how these post-printing steps combine with the deposition method to determine the final construct.

Applications

Bioprinting has applications in a range of fields, including:

• Tissue engineering of skin, cartilage, bone, and corneal grafts
• Organ-on-a-chip and microphysiological systems for physiology research
• Drug screening and toxicology testing on human-derived tissue models
• Tumor models that reproduce three-dimensional microenvironments for cancer research
• Patient-specific implant and scaffold fabrication from imaging data
• Wound healing research, including in situ printing directly onto a defect site
• Cultivated meat and non-animal testing platforms for cosmetics